193 related articles for article (PubMed ID: 34864772)
1. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
2. Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.
Hicks BM; Busby J; Mills K; O'Neil FA; McIntosh SA; Zhang SD; Liberante FG; Cardwell CR
BMC Cancer; 2020 Aug; 20(1):804. PubMed ID: 32831062
[TBL] [Abstract][Full Text] [Related]
3. Dopamine antagonists and the development of breast cancer.
Wang PS; Walker AM; Tsuang MT; Orav EJ; Glynn RJ; Levin R; Avorn J
Arch Gen Psychiatry; 2002 Dec; 59(12):1147-54. PubMed ID: 12470131
[TBL] [Abstract][Full Text] [Related]
4. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
5. Risk of breast cancer in risperidone users: A nationwide cohort study.
Reutfors J; Wingård L; Brandt L; Wang Y; Qiu H; Kieler H; Bahmanyar S
Schizophr Res; 2017 Apr; 182():98-103. PubMed ID: 27823949
[TBL] [Abstract][Full Text] [Related]
6. Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer.
Klil-Drori AJ; Yin H; Abenhaim HA; du Fort GG; Azoulay L
J Clin Psychiatry; 2017 Jun; 78(6):714-719. PubMed ID: 28199787
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.
Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013
[TBL] [Abstract][Full Text] [Related]
9. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Limitations of the Odds Ratio in a Case-Control Study of the Association Between Breast Cancer and Exposure to Antipsychotic Drugs.
Andrade C
J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34813689
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
12. Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
Wu Chou AI; Wang YC; Lin CL; Kao CH
Schizophr Res; 2017 Oct; 188():165-171. PubMed ID: 28108225
[TBL] [Abstract][Full Text] [Related]
13. Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals.
Leung JCN; Ng DWY; Chu RYK; Chan EWW; Huang L; Lum DH; Chan EWY; Smith DJ; Wong ICK; Lai FTT
Epidemiol Psychiatr Sci; 2022 Sep; 31():e61. PubMed ID: 36059215
[TBL] [Abstract][Full Text] [Related]
14. The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.
Shen SP; Liu Y; Qiu H; Tsai KY; Wu HC; Liang WM; Shu M; Chou FH
PLoS One; 2019; 14(9):e0221948. PubMed ID: 31487309
[TBL] [Abstract][Full Text] [Related]
15. Association between consistent purchase of anticonvulsants or lithium and suicide risk: a longitudinal cohort study from Denmark, 1995-2001.
Smith EG; Søndergård L; Lopez AG; Andersen PK; Kessing LV
J Affect Disord; 2009 Oct; 117(3):162-7. PubMed ID: 19243837
[TBL] [Abstract][Full Text] [Related]
16. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer in hospitalized psychiatric patients.
Goode DJ; Corbett WT; Schey HM; Suh SH; Woodie B; Morris DL; Morrisey L
Am J Psychiatry; 1981 Jun; 138(6):804-6. PubMed ID: 6113769
[TBL] [Abstract][Full Text] [Related]
18. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy.
Epstein RA; Bobo WV; Shelton RC; Arbogast PG; Morrow JA; Wang W; Chandrasekhar R; Cooper WO
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):794-801. PubMed ID: 23124892
[TBL] [Abstract][Full Text] [Related]
19. [Hyperprolactinemia in mentally ill patients].
Carvalho MM; Góis C
Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic treatment, prolactin, and breast tumorigenesis.
De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]